Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients.

Benedikt Hoeh Rocco Simone Flammia Lukas HohenhorstGabriele SorceFrancesco ChierigoZhe TianFred SaadMichele GallucciAlberto BrigantiCarlo TerroneShahrokh F ShariatMarkus GraefenDerya TilkiLuis A KluthPhilipp MandelAndreas BeckerFelix K H ChunPierre I Karakiewicz

Published in: The Prostate (2022)

In cT1c-stage patients with high-risk PSA baseline, but low- to intermediate risk B-GGG, the rate of upgrading to GGG4 or GGG5 is low (11%). However, NOC stage is found in the majority (51%) and can be independently predicted with percentage of positive cores at biopsy and B-GGG.

Keyphrases

prostate cancer
radical prostatectomy
ultrasound guided
image quality
contrast enhanced